nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A7—Tamoxifen—pancreatic cancer	0.0617	0.0922	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0617	0.0922	CbGbCtD
Oxycodone—CYP3A7—Irinotecan—pancreatic cancer	0.0474	0.0708	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0474	0.0708	CbGbCtD
Oxycodone—CYP3A5—Tamoxifen—pancreatic cancer	0.0463	0.0691	CbGbCtD
Oxycodone—CYP3A5—Erlotinib—pancreatic cancer	0.0394	0.0588	CbGbCtD
Oxycodone—CYP3A5—Irinotecan—pancreatic cancer	0.0356	0.0531	CbGbCtD
Oxycodone—CYP3A7—Docetaxel—pancreatic cancer	0.0347	0.0519	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0347	0.0519	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0346	0.0516	CbGbCtD
Oxycodone—CYP3A7—Sunitinib—pancreatic cancer	0.0346	0.0516	CbGbCtD
Oxycodone—CYP2D6—Tamoxifen—pancreatic cancer	0.0284	0.0424	CbGbCtD
Oxycodone—CYP3A5—Docetaxel—pancreatic cancer	0.0261	0.0389	CbGbCtD
Oxycodone—CYP3A5—Sunitinib—pancreatic cancer	0.0259	0.0387	CbGbCtD
Oxycodone—CYP2D6—Erlotinib—pancreatic cancer	0.0241	0.0361	CbGbCtD
Oxycodone—CYP3A4—Tamoxifen—pancreatic cancer	0.0181	0.027	CbGbCtD
Oxycodone—CYP3A4—Erlotinib—pancreatic cancer	0.0154	0.0229	CbGbCtD
Oxycodone—CYP3A4—Irinotecan—pancreatic cancer	0.0139	0.0207	CbGbCtD
Oxycodone—CYP2D6—Doxorubicin—pancreatic cancer	0.0119	0.0178	CbGbCtD
Oxycodone—CYP3A4—Docetaxel—pancreatic cancer	0.0102	0.0152	CbGbCtD
Oxycodone—CYP3A4—Sunitinib—pancreatic cancer	0.0101	0.0151	CbGbCtD
Oxycodone—CYP3A4—Doxorubicin—pancreatic cancer	0.00758	0.0113	CbGbCtD
Oxycodone—Asthenia—Irinotecan—pancreatic cancer	0.000136	0.000519	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000135	0.000518	CcSEcCtD
Oxycodone—Stomatitis—Epirubicin—pancreatic cancer	0.000135	0.000516	CcSEcCtD
Oxycodone—Urinary tract infection—Epirubicin—pancreatic cancer	0.000134	0.000514	CcSEcCtD
Oxycodone—Dysuria—Doxorubicin—pancreatic cancer	0.000134	0.000513	CcSEcCtD
Oxycodone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000133	0.000511	CcSEcCtD
Oxycodone—Dry mouth—Docetaxel—pancreatic cancer	0.000133	0.00051	CcSEcCtD
Oxycodone—Sweating—Epirubicin—pancreatic cancer	0.000132	0.000507	CcSEcCtD
Oxycodone—Asthenia—Gemcitabine—pancreatic cancer	0.000132	0.000506	CcSEcCtD
Oxycodone—Haematuria—Epirubicin—pancreatic cancer	0.000132	0.000504	CcSEcCtD
Oxycodone—Confusional state—Docetaxel—pancreatic cancer	0.000132	0.000504	CcSEcCtD
Oxycodone—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000131	0.000501	CcSEcCtD
Oxycodone—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000131	0.0005	CcSEcCtD
Oxycodone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000131	0.0005	CcSEcCtD
Oxycodone—Oedema—Docetaxel—pancreatic cancer	0.000131	0.0005	CcSEcCtD
Oxycodone—Epistaxis—Epirubicin—pancreatic cancer	0.00013	0.000499	CcSEcCtD
Oxycodone—Pruritus—Gemcitabine—pancreatic cancer	0.00013	0.000499	CcSEcCtD
Oxycodone—Infection—Docetaxel—pancreatic cancer	0.00013	0.000497	CcSEcCtD
Oxycodone—Weight decreased—Doxorubicin—pancreatic cancer	0.00013	0.000497	CcSEcCtD
Oxycodone—Sinusitis—Epirubicin—pancreatic cancer	0.00013	0.000496	CcSEcCtD
Oxycodone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000129	0.000495	CcSEcCtD
Oxycodone—Diarrhoea—Irinotecan—pancreatic cancer	0.000129	0.000495	CcSEcCtD
Oxycodone—Pneumonia—Doxorubicin—pancreatic cancer	0.000129	0.000492	CcSEcCtD
Oxycodone—Shock—Docetaxel—pancreatic cancer	0.000129	0.000492	CcSEcCtD
Oxycodone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000128	0.000491	CcSEcCtD
Oxycodone—Pruritus—Fluorouracil—pancreatic cancer	0.000128	0.00049	CcSEcCtD
Oxycodone—Infestation—Doxorubicin—pancreatic cancer	0.000128	0.000489	CcSEcCtD
Oxycodone—Drowsiness—Doxorubicin—pancreatic cancer	0.000128	0.000489	CcSEcCtD
Oxycodone—Infestation NOS—Doxorubicin—pancreatic cancer	0.000128	0.000489	CcSEcCtD
Oxycodone—Tachycardia—Docetaxel—pancreatic cancer	0.000128	0.000488	CcSEcCtD
Oxycodone—Skin disorder—Docetaxel—pancreatic cancer	0.000127	0.000486	CcSEcCtD
Oxycodone—Bradycardia—Epirubicin—pancreatic cancer	0.000126	0.000483	CcSEcCtD
Oxycodone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000126	0.000482	CcSEcCtD
Oxycodone—Dizziness—Irinotecan—pancreatic cancer	0.000125	0.000478	CcSEcCtD
Oxycodone—Haemoglobin—Epirubicin—pancreatic cancer	0.000125	0.000477	CcSEcCtD
Oxycodone—Stomatitis—Doxorubicin—pancreatic cancer	0.000125	0.000477	CcSEcCtD
Oxycodone—Anorexia—Docetaxel—pancreatic cancer	0.000125	0.000477	CcSEcCtD
Oxycodone—Rhinitis—Epirubicin—pancreatic cancer	0.000124	0.000476	CcSEcCtD
Oxycodone—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000124	0.000476	CcSEcCtD
Oxycodone—Haemorrhage—Epirubicin—pancreatic cancer	0.000124	0.000475	CcSEcCtD
Oxycodone—Hepatitis—Epirubicin—pancreatic cancer	0.000124	0.000475	CcSEcCtD
Oxycodone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000124	0.000474	CcSEcCtD
Oxycodone—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000123	0.000472	CcSEcCtD
Oxycodone—Pharyngitis—Epirubicin—pancreatic cancer	0.000123	0.000471	CcSEcCtD
Oxycodone—Sweating—Doxorubicin—pancreatic cancer	0.000123	0.000469	CcSEcCtD
Oxycodone—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000123	0.000469	CcSEcCtD
Oxycodone—Oedema peripheral—Epirubicin—pancreatic cancer	0.000122	0.000468	CcSEcCtD
Oxycodone—Hypotension—Docetaxel—pancreatic cancer	0.000122	0.000467	CcSEcCtD
Oxycodone—Haematuria—Doxorubicin—pancreatic cancer	0.000122	0.000467	CcSEcCtD
Oxycodone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000122	0.000467	CcSEcCtD
Oxycodone—Urethral disorder—Epirubicin—pancreatic cancer	0.000122	0.000466	CcSEcCtD
Oxycodone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000121	0.000463	CcSEcCtD
Oxycodone—Epistaxis—Doxorubicin—pancreatic cancer	0.000121	0.000462	CcSEcCtD
Oxycodone—Vomiting—Irinotecan—pancreatic cancer	0.00012	0.00046	CcSEcCtD
Oxycodone—Sinusitis—Doxorubicin—pancreatic cancer	0.00012	0.000459	CcSEcCtD
Oxycodone—Dizziness—Fluorouracil—pancreatic cancer	0.00012	0.000458	CcSEcCtD
Oxycodone—Visual impairment—Epirubicin—pancreatic cancer	0.00012	0.000458	CcSEcCtD
Oxycodone—Rash—Irinotecan—pancreatic cancer	0.000119	0.000456	CcSEcCtD
Oxycodone—Dermatitis—Irinotecan—pancreatic cancer	0.000119	0.000456	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000119	0.000456	CcSEcCtD
Oxycodone—Headache—Irinotecan—pancreatic cancer	0.000118	0.000453	CcSEcCtD
Oxycodone—Insomnia—Docetaxel—pancreatic cancer	0.000118	0.000452	CcSEcCtD
Oxycodone—Paraesthesia—Docetaxel—pancreatic cancer	0.000117	0.000449	CcSEcCtD
Oxycodone—Vomiting—Gemcitabine—pancreatic cancer	0.000117	0.000448	CcSEcCtD
Oxycodone—Bradycardia—Doxorubicin—pancreatic cancer	0.000117	0.000447	CcSEcCtD
Oxycodone—Dyspnoea—Docetaxel—pancreatic cancer	0.000116	0.000446	CcSEcCtD
Oxycodone—Somnolence—Docetaxel—pancreatic cancer	0.000116	0.000445	CcSEcCtD
Oxycodone—Rash—Gemcitabine—pancreatic cancer	0.000116	0.000444	CcSEcCtD
Oxycodone—Dermatitis—Gemcitabine—pancreatic cancer	0.000116	0.000444	CcSEcCtD
Oxycodone—Eye disorder—Epirubicin—pancreatic cancer	0.000116	0.000444	CcSEcCtD
Oxycodone—Tinnitus—Epirubicin—pancreatic cancer	0.000116	0.000443	CcSEcCtD
Oxycodone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000115	0.000442	CcSEcCtD
Oxycodone—Headache—Gemcitabine—pancreatic cancer	0.000115	0.000442	CcSEcCtD
Oxycodone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000115	0.000441	CcSEcCtD
Oxycodone—Flushing—Epirubicin—pancreatic cancer	0.000115	0.000441	CcSEcCtD
Oxycodone—Vomiting—Fluorouracil—pancreatic cancer	0.000115	0.000441	CcSEcCtD
Oxycodone—Rhinitis—Doxorubicin—pancreatic cancer	0.000115	0.000441	CcSEcCtD
Oxycodone—Dyspepsia—Docetaxel—pancreatic cancer	0.000115	0.00044	CcSEcCtD
Oxycodone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000115	0.000439	CcSEcCtD
Oxycodone—Hepatitis—Doxorubicin—pancreatic cancer	0.000115	0.000439	CcSEcCtD
Oxycodone—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000114	0.000437	CcSEcCtD
Oxycodone—Rash—Fluorouracil—pancreatic cancer	0.000114	0.000437	CcSEcCtD
Oxycodone—Dermatitis—Fluorouracil—pancreatic cancer	0.000114	0.000437	CcSEcCtD
Oxycodone—Pharyngitis—Doxorubicin—pancreatic cancer	0.000114	0.000436	CcSEcCtD
Oxycodone—Decreased appetite—Docetaxel—pancreatic cancer	0.000114	0.000435	CcSEcCtD
Oxycodone—Headache—Fluorouracil—pancreatic cancer	0.000113	0.000434	CcSEcCtD
Oxycodone—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000113	0.000434	CcSEcCtD
Oxycodone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000113	0.000433	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000113	0.000432	CcSEcCtD
Oxycodone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000113	0.000432	CcSEcCtD
Oxycodone—Fatigue—Docetaxel—pancreatic cancer	0.000113	0.000431	CcSEcCtD
Oxycodone—Angiopathy—Epirubicin—pancreatic cancer	0.000113	0.000431	CcSEcCtD
Oxycodone—Urethral disorder—Doxorubicin—pancreatic cancer	0.000113	0.000431	CcSEcCtD
Oxycodone—Nausea—Irinotecan—pancreatic cancer	0.000112	0.00043	CcSEcCtD
Oxycodone—Immune system disorder—Epirubicin—pancreatic cancer	0.000112	0.000429	CcSEcCtD
Oxycodone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000112	0.000428	CcSEcCtD
Oxycodone—Pain—Docetaxel—pancreatic cancer	0.000112	0.000428	CcSEcCtD
Oxycodone—Constipation—Docetaxel—pancreatic cancer	0.000112	0.000428	CcSEcCtD
Oxycodone—Chills—Epirubicin—pancreatic cancer	0.000111	0.000426	CcSEcCtD
Oxycodone—Visual impairment—Doxorubicin—pancreatic cancer	0.000111	0.000423	CcSEcCtD
Oxycodone—Nausea—Gemcitabine—pancreatic cancer	0.000109	0.000419	CcSEcCtD
Oxycodone—Mental disorder—Epirubicin—pancreatic cancer	0.000109	0.000416	CcSEcCtD
Oxycodone—Malnutrition—Epirubicin—pancreatic cancer	0.000108	0.000413	CcSEcCtD
Oxycodone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000108	0.000412	CcSEcCtD
Oxycodone—Nausea—Fluorouracil—pancreatic cancer	0.000108	0.000412	CcSEcCtD
Oxycodone—Eye disorder—Doxorubicin—pancreatic cancer	0.000107	0.000411	CcSEcCtD
Oxycodone—Tinnitus—Doxorubicin—pancreatic cancer	0.000107	0.00041	CcSEcCtD
Oxycodone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000107	0.000409	CcSEcCtD
Oxycodone—Flushing—Doxorubicin—pancreatic cancer	0.000107	0.000408	CcSEcCtD
Oxycodone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000107	0.000408	CcSEcCtD
Oxycodone—Flatulence—Epirubicin—pancreatic cancer	0.000106	0.000407	CcSEcCtD
Oxycodone—Tension—Epirubicin—pancreatic cancer	0.000106	0.000406	CcSEcCtD
Oxycodone—Dysgeusia—Epirubicin—pancreatic cancer	0.000106	0.000405	CcSEcCtD
Oxycodone—Nervousness—Epirubicin—pancreatic cancer	0.000105	0.000401	CcSEcCtD
Oxycodone—Back pain—Epirubicin—pancreatic cancer	0.000104	0.0004	CcSEcCtD
Oxycodone—Angiopathy—Doxorubicin—pancreatic cancer	0.000104	0.000399	CcSEcCtD
Oxycodone—Muscle spasms—Epirubicin—pancreatic cancer	0.000104	0.000397	CcSEcCtD
Oxycodone—Immune system disorder—Doxorubicin—pancreatic cancer	0.000104	0.000397	CcSEcCtD
Oxycodone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000103	0.000396	CcSEcCtD
Oxycodone—Abdominal pain—Docetaxel—pancreatic cancer	0.000103	0.000395	CcSEcCtD
Oxycodone—Body temperature increased—Docetaxel—pancreatic cancer	0.000103	0.000395	CcSEcCtD
Oxycodone—Chills—Doxorubicin—pancreatic cancer	0.000103	0.000394	CcSEcCtD
Oxycodone—Mental disorder—Doxorubicin—pancreatic cancer	0.000101	0.000385	CcSEcCtD
Oxycodone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.0001	0.000384	CcSEcCtD
Oxycodone—Malnutrition—Doxorubicin—pancreatic cancer	9.99e-05	0.000382	CcSEcCtD
Oxycodone—Anaemia—Epirubicin—pancreatic cancer	9.98e-05	0.000382	CcSEcCtD
Oxycodone—Agitation—Epirubicin—pancreatic cancer	9.92e-05	0.00038	CcSEcCtD
Oxycodone—Flatulence—Doxorubicin—pancreatic cancer	9.85e-05	0.000377	CcSEcCtD
Oxycodone—Tension—Doxorubicin—pancreatic cancer	9.8e-05	0.000375	CcSEcCtD
Oxycodone—Dysgeusia—Doxorubicin—pancreatic cancer	9.78e-05	0.000375	CcSEcCtD
Oxycodone—Malaise—Epirubicin—pancreatic cancer	9.74e-05	0.000373	CcSEcCtD
Oxycodone—Nervousness—Doxorubicin—pancreatic cancer	9.7e-05	0.000371	CcSEcCtD
Oxycodone—Vertigo—Epirubicin—pancreatic cancer	9.7e-05	0.000371	CcSEcCtD
Oxycodone—Syncope—Epirubicin—pancreatic cancer	9.68e-05	0.000371	CcSEcCtD
Oxycodone—Leukopenia—Epirubicin—pancreatic cancer	9.67e-05	0.00037	CcSEcCtD
Oxycodone—Back pain—Doxorubicin—pancreatic cancer	9.66e-05	0.00037	CcSEcCtD
Oxycodone—Hypersensitivity—Docetaxel—pancreatic cancer	9.63e-05	0.000369	CcSEcCtD
Oxycodone—Muscle spasms—Doxorubicin—pancreatic cancer	9.61e-05	0.000368	CcSEcCtD
Oxycodone—Palpitations—Epirubicin—pancreatic cancer	9.54e-05	0.000365	CcSEcCtD
Oxycodone—Loss of consciousness—Epirubicin—pancreatic cancer	9.49e-05	0.000363	CcSEcCtD
Oxycodone—Cough—Epirubicin—pancreatic cancer	9.42e-05	0.000361	CcSEcCtD
Oxycodone—Asthenia—Docetaxel—pancreatic cancer	9.37e-05	0.000359	CcSEcCtD
Oxycodone—Convulsion—Epirubicin—pancreatic cancer	9.36e-05	0.000358	CcSEcCtD
Oxycodone—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.27e-05	0.000355	CcSEcCtD
Oxycodone—Pruritus—Docetaxel—pancreatic cancer	9.24e-05	0.000354	CcSEcCtD
Oxycodone—Anaemia—Doxorubicin—pancreatic cancer	9.23e-05	0.000354	CcSEcCtD
Oxycodone—Arthralgia—Epirubicin—pancreatic cancer	9.19e-05	0.000352	CcSEcCtD
Oxycodone—Chest pain—Epirubicin—pancreatic cancer	9.19e-05	0.000352	CcSEcCtD
Oxycodone—Myalgia—Epirubicin—pancreatic cancer	9.19e-05	0.000352	CcSEcCtD
Oxycodone—Agitation—Doxorubicin—pancreatic cancer	9.18e-05	0.000352	CcSEcCtD
Oxycodone—Anxiety—Epirubicin—pancreatic cancer	9.16e-05	0.000351	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	9.13e-05	0.00035	CcSEcCtD
Oxycodone—Discomfort—Epirubicin—pancreatic cancer	9.08e-05	0.000348	CcSEcCtD
Oxycodone—Malaise—Doxorubicin—pancreatic cancer	9.01e-05	0.000345	CcSEcCtD
Oxycodone—Dry mouth—Epirubicin—pancreatic cancer	8.99e-05	0.000344	CcSEcCtD
Oxycodone—Vertigo—Doxorubicin—pancreatic cancer	8.98e-05	0.000344	CcSEcCtD
Oxycodone—Syncope—Doxorubicin—pancreatic cancer	8.96e-05	0.000343	CcSEcCtD
Oxycodone—Leukopenia—Doxorubicin—pancreatic cancer	8.94e-05	0.000342	CcSEcCtD
Oxycodone—Diarrhoea—Docetaxel—pancreatic cancer	8.94e-05	0.000342	CcSEcCtD
Oxycodone—Confusional state—Epirubicin—pancreatic cancer	8.89e-05	0.00034	CcSEcCtD
Oxycodone—Palpitations—Doxorubicin—pancreatic cancer	8.83e-05	0.000338	CcSEcCtD
Oxycodone—Oedema—Epirubicin—pancreatic cancer	8.81e-05	0.000337	CcSEcCtD
Oxycodone—Anaphylactic shock—Epirubicin—pancreatic cancer	8.81e-05	0.000337	CcSEcCtD
Oxycodone—Loss of consciousness—Doxorubicin—pancreatic cancer	8.78e-05	0.000336	CcSEcCtD
Oxycodone—Infection—Epirubicin—pancreatic cancer	8.76e-05	0.000335	CcSEcCtD
Oxycodone—Cough—Doxorubicin—pancreatic cancer	8.72e-05	0.000334	CcSEcCtD
Oxycodone—Shock—Epirubicin—pancreatic cancer	8.67e-05	0.000332	CcSEcCtD
Oxycodone—Convulsion—Doxorubicin—pancreatic cancer	8.66e-05	0.000331	CcSEcCtD
Oxycodone—Nervous system disorder—Epirubicin—pancreatic cancer	8.64e-05	0.000331	CcSEcCtD
Oxycodone—Dizziness—Docetaxel—pancreatic cancer	8.64e-05	0.000331	CcSEcCtD
Oxycodone—Tachycardia—Epirubicin—pancreatic cancer	8.6e-05	0.000329	CcSEcCtD
Oxycodone—Skin disorder—Epirubicin—pancreatic cancer	8.56e-05	0.000328	CcSEcCtD
Oxycodone—Hyperhidrosis—Epirubicin—pancreatic cancer	8.52e-05	0.000326	CcSEcCtD
Oxycodone—Arthralgia—Doxorubicin—pancreatic cancer	8.51e-05	0.000326	CcSEcCtD
Oxycodone—Chest pain—Doxorubicin—pancreatic cancer	8.51e-05	0.000326	CcSEcCtD
Oxycodone—Myalgia—Doxorubicin—pancreatic cancer	8.51e-05	0.000326	CcSEcCtD
Oxycodone—Anxiety—Doxorubicin—pancreatic cancer	8.48e-05	0.000325	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.45e-05	0.000323	CcSEcCtD
Oxycodone—Discomfort—Doxorubicin—pancreatic cancer	8.4e-05	0.000322	CcSEcCtD
Oxycodone—Anorexia—Epirubicin—pancreatic cancer	8.4e-05	0.000322	CcSEcCtD
Oxycodone—Dry mouth—Doxorubicin—pancreatic cancer	8.32e-05	0.000318	CcSEcCtD
Oxycodone—Vomiting—Docetaxel—pancreatic cancer	8.31e-05	0.000318	CcSEcCtD
Oxycodone—Rash—Docetaxel—pancreatic cancer	8.24e-05	0.000315	CcSEcCtD
Oxycodone—Hypotension—Epirubicin—pancreatic cancer	8.24e-05	0.000315	CcSEcCtD
Oxycodone—Dermatitis—Docetaxel—pancreatic cancer	8.23e-05	0.000315	CcSEcCtD
Oxycodone—Confusional state—Doxorubicin—pancreatic cancer	8.22e-05	0.000315	CcSEcCtD
Oxycodone—Headache—Docetaxel—pancreatic cancer	8.19e-05	0.000313	CcSEcCtD
Oxycodone—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.15e-05	0.000312	CcSEcCtD
Oxycodone—Oedema—Doxorubicin—pancreatic cancer	8.15e-05	0.000312	CcSEcCtD
Oxycodone—Infection—Doxorubicin—pancreatic cancer	8.1e-05	0.00031	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.03e-05	0.000307	CcSEcCtD
Oxycodone—Shock—Doxorubicin—pancreatic cancer	8.02e-05	0.000307	CcSEcCtD
Oxycodone—Nervous system disorder—Doxorubicin—pancreatic cancer	8e-05	0.000306	CcSEcCtD
Oxycodone—Insomnia—Epirubicin—pancreatic cancer	7.97e-05	0.000305	CcSEcCtD
Oxycodone—Tachycardia—Doxorubicin—pancreatic cancer	7.96e-05	0.000305	CcSEcCtD
Oxycodone—Skin disorder—Doxorubicin—pancreatic cancer	7.92e-05	0.000303	CcSEcCtD
Oxycodone—Paraesthesia—Epirubicin—pancreatic cancer	7.91e-05	0.000303	CcSEcCtD
Oxycodone—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.88e-05	0.000302	CcSEcCtD
Oxycodone—Dyspnoea—Epirubicin—pancreatic cancer	7.86e-05	0.000301	CcSEcCtD
Oxycodone—Somnolence—Epirubicin—pancreatic cancer	7.83e-05	0.0003	CcSEcCtD
Oxycodone—Anorexia—Doxorubicin—pancreatic cancer	7.77e-05	0.000298	CcSEcCtD
Oxycodone—Nausea—Docetaxel—pancreatic cancer	7.76e-05	0.000297	CcSEcCtD
Oxycodone—Dyspepsia—Epirubicin—pancreatic cancer	7.76e-05	0.000297	CcSEcCtD
Oxycodone—Decreased appetite—Epirubicin—pancreatic cancer	7.66e-05	0.000293	CcSEcCtD
Oxycodone—Hypotension—Doxorubicin—pancreatic cancer	7.62e-05	0.000292	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.61e-05	0.000291	CcSEcCtD
Oxycodone—Fatigue—Epirubicin—pancreatic cancer	7.6e-05	0.000291	CcSEcCtD
Oxycodone—Constipation—Epirubicin—pancreatic cancer	7.54e-05	0.000289	CcSEcCtD
Oxycodone—Pain—Epirubicin—pancreatic cancer	7.54e-05	0.000289	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.43e-05	0.000284	CcSEcCtD
Oxycodone—Insomnia—Doxorubicin—pancreatic cancer	7.38e-05	0.000282	CcSEcCtD
Oxycodone—Paraesthesia—Doxorubicin—pancreatic cancer	7.32e-05	0.00028	CcSEcCtD
Oxycodone—Dyspnoea—Doxorubicin—pancreatic cancer	7.27e-05	0.000278	CcSEcCtD
Oxycodone—Feeling abnormal—Epirubicin—pancreatic cancer	7.26e-05	0.000278	CcSEcCtD
Oxycodone—Somnolence—Doxorubicin—pancreatic cancer	7.25e-05	0.000278	CcSEcCtD
Oxycodone—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.21e-05	0.000276	CcSEcCtD
Oxycodone—Dyspepsia—Doxorubicin—pancreatic cancer	7.18e-05	0.000275	CcSEcCtD
Oxycodone—Decreased appetite—Doxorubicin—pancreatic cancer	7.09e-05	0.000271	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.04e-05	0.00027	CcSEcCtD
Oxycodone—Fatigue—Doxorubicin—pancreatic cancer	7.03e-05	0.000269	CcSEcCtD
Oxycodone—Urticaria—Epirubicin—pancreatic cancer	7e-05	0.000268	CcSEcCtD
Oxycodone—Constipation—Doxorubicin—pancreatic cancer	6.97e-05	0.000267	CcSEcCtD
Oxycodone—Pain—Doxorubicin—pancreatic cancer	6.97e-05	0.000267	CcSEcCtD
Oxycodone—Abdominal pain—Epirubicin—pancreatic cancer	6.97e-05	0.000267	CcSEcCtD
Oxycodone—Body temperature increased—Epirubicin—pancreatic cancer	6.97e-05	0.000267	CcSEcCtD
Oxycodone—Feeling abnormal—Doxorubicin—pancreatic cancer	6.72e-05	0.000257	CcSEcCtD
Oxycodone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.67e-05	0.000255	CcSEcCtD
Oxycodone—Hypersensitivity—Epirubicin—pancreatic cancer	6.49e-05	0.000249	CcSEcCtD
Oxycodone—Urticaria—Doxorubicin—pancreatic cancer	6.48e-05	0.000248	CcSEcCtD
Oxycodone—Abdominal pain—Doxorubicin—pancreatic cancer	6.45e-05	0.000247	CcSEcCtD
Oxycodone—Body temperature increased—Doxorubicin—pancreatic cancer	6.45e-05	0.000247	CcSEcCtD
Oxycodone—Asthenia—Epirubicin—pancreatic cancer	6.32e-05	0.000242	CcSEcCtD
Oxycodone—Pruritus—Epirubicin—pancreatic cancer	6.24e-05	0.000239	CcSEcCtD
Oxycodone—Diarrhoea—Epirubicin—pancreatic cancer	6.03e-05	0.000231	CcSEcCtD
Oxycodone—Hypersensitivity—Doxorubicin—pancreatic cancer	6.01e-05	0.00023	CcSEcCtD
Oxycodone—Asthenia—Doxorubicin—pancreatic cancer	5.85e-05	0.000224	CcSEcCtD
Oxycodone—Dizziness—Epirubicin—pancreatic cancer	5.83e-05	0.000223	CcSEcCtD
Oxycodone—Pruritus—Doxorubicin—pancreatic cancer	5.77e-05	0.000221	CcSEcCtD
Oxycodone—Vomiting—Epirubicin—pancreatic cancer	5.6e-05	0.000215	CcSEcCtD
Oxycodone—Diarrhoea—Doxorubicin—pancreatic cancer	5.58e-05	0.000214	CcSEcCtD
Oxycodone—Rash—Epirubicin—pancreatic cancer	5.56e-05	0.000213	CcSEcCtD
Oxycodone—Dermatitis—Epirubicin—pancreatic cancer	5.55e-05	0.000213	CcSEcCtD
Oxycodone—Headache—Epirubicin—pancreatic cancer	5.52e-05	0.000211	CcSEcCtD
Oxycodone—Dizziness—Doxorubicin—pancreatic cancer	5.39e-05	0.000206	CcSEcCtD
Oxycodone—Nausea—Epirubicin—pancreatic cancer	5.23e-05	0.0002	CcSEcCtD
Oxycodone—Vomiting—Doxorubicin—pancreatic cancer	5.18e-05	0.000198	CcSEcCtD
Oxycodone—Rash—Doxorubicin—pancreatic cancer	5.14e-05	0.000197	CcSEcCtD
Oxycodone—Dermatitis—Doxorubicin—pancreatic cancer	5.14e-05	0.000197	CcSEcCtD
Oxycodone—Headache—Doxorubicin—pancreatic cancer	5.11e-05	0.000196	CcSEcCtD
Oxycodone—Nausea—Doxorubicin—pancreatic cancer	4.84e-05	0.000185	CcSEcCtD
Oxycodone—CYP3A5—Metabolism—ARG2—pancreatic cancer	3.53e-05	0.000513	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	3.53e-05	0.000513	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SST—pancreatic cancer	3.52e-05	0.00051	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	3.51e-05	0.00051	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.47e-05	0.000503	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GLP1R—pancreatic cancer	3.45e-05	0.0005	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	3.44e-05	0.000499	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCK—pancreatic cancer	3.44e-05	0.000499	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	3.43e-05	0.000497	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—DPYD—pancreatic cancer	3.39e-05	0.000492	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	3.37e-05	0.000489	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	3.37e-05	0.000489	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	3.35e-05	0.000486	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	3.35e-05	0.000486	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	3.35e-05	0.000486	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	3.3e-05	0.000478	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	3.24e-05	0.000471	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	3.22e-05	0.000467	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	3.2e-05	0.000464	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	3.15e-05	0.000457	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.15e-05	0.000457	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GCG—pancreatic cancer	3.13e-05	0.000455	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TYMP—pancreatic cancer	3.09e-05	0.000448	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SST—pancreatic cancer	3.08e-05	0.000447	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.05e-05	0.000442	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.04e-05	0.000441	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	3.02e-05	0.000438	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SHH—pancreatic cancer	3e-05	0.000436	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	3e-05	0.000436	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	2.99e-05	0.000434	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	2.99e-05	0.000433	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	2.97e-05	0.000431	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STK11—pancreatic cancer	2.95e-05	0.000428	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.9e-05	0.000421	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	2.85e-05	0.000413	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	2.85e-05	0.000413	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	2.84e-05	0.000413	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.77e-05	0.000402	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.76e-05	0.000401	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GCG—pancreatic cancer	2.75e-05	0.000399	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.67e-05	0.000388	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.66e-05	0.000386	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	2.62e-05	0.00038	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SST—pancreatic cancer	2.61e-05	0.000378	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STK11—pancreatic cancer	2.58e-05	0.000375	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	2.58e-05	0.000374	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.57e-05	0.000373	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.55e-05	0.000371	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	2.55e-05	0.00037	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	2.54e-05	0.000368	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HES1—pancreatic cancer	2.52e-05	0.000366	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.51e-05	0.000365	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CD44—pancreatic cancer	2.49e-05	0.000362	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GLP1R—pancreatic cancer	2.49e-05	0.000361	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—DPYD—pancreatic cancer	2.45e-05	0.000356	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.43e-05	0.000352	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.41e-05	0.00035	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	2.4e-05	0.000349	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GCG—pancreatic cancer	2.39e-05	0.000347	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.33e-05	0.000339	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.33e-05	0.000338	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	2.33e-05	0.000337	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GCG—pancreatic cancer	2.32e-05	0.000337	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	2.32e-05	0.000336	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	2.26e-05	0.000328	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.26e-05	0.000328	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—STK11—pancreatic cancer	2.25e-05	0.000326	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.24e-05	0.000325	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.22e-05	0.000321	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HES1—pancreatic cancer	2.21e-05	0.000321	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TERT—pancreatic cancer	2.21e-05	0.00032	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.2e-05	0.000319	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STK11—pancreatic cancer	2.18e-05	0.000317	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.12e-05	0.000307	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	2.11e-05	0.000306	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	2.11e-05	0.000306	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APOE—pancreatic cancer	2.06e-05	0.000299	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.05e-05	0.000298	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	2.03e-05	0.000295	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KDR—pancreatic cancer	2.02e-05	0.000293	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.97e-05	0.000286	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TERT—pancreatic cancer	1.94e-05	0.000281	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TYMS—pancreatic cancer	1.93e-05	0.00028	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	1.92e-05	0.000279	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	1.91e-05	0.000278	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	1.9e-05	0.000276	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.9e-05	0.000275	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.89e-05	0.000275	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HES1—pancreatic cancer	1.87e-05	0.000271	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	1.86e-05	0.00027	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	1.86e-05	0.00027	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	1.85e-05	0.000269	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	1.85e-05	0.000268	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGF—pancreatic cancer	1.84e-05	0.000267	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOE—pancreatic cancer	1.81e-05	0.000262	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CD44—pancreatic cancer	1.8e-05	0.000261	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.79e-05	0.000259	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.77e-05	0.000257	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KDR—pancreatic cancer	1.77e-05	0.000257	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.74e-05	0.000253	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GCG—pancreatic cancer	1.73e-05	0.000251	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	1.72e-05	0.000249	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	1.69e-05	0.000246	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	1.68e-05	0.000244	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	1.67e-05	0.000242	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.65e-05	0.00024	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.64e-05	0.000239	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—pancreatic cancer	1.64e-05	0.000237	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	1.64e-05	0.000237	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	1.63e-05	0.000237	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	1.63e-05	0.000237	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—STK11—pancreatic cancer	1.62e-05	0.000236	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.62e-05	0.000235	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGF—pancreatic cancer	1.61e-05	0.000234	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	1.6e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOE—pancreatic cancer	1.57e-05	0.000228	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	1.56e-05	0.000227	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	1.56e-05	0.000226	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOE—pancreatic cancer	1.53e-05	0.000222	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—pancreatic cancer	1.5e-05	0.000217	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	1.49e-05	0.000216	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.47e-05	0.000213	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.44e-05	0.000208	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	1.43e-05	0.000208	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	1.43e-05	0.000207	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.42e-05	0.000207	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.42e-05	0.000206	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.42e-05	0.000206	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.41e-05	0.000205	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	1.4e-05	0.000204	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.4e-05	0.000203	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.38e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.38e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.37e-05	0.000199	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.37e-05	0.000199	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGF—pancreatic cancer	1.36e-05	0.000198	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.36e-05	0.000197	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.32e-05	0.000192	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	1.31e-05	0.00019	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.29e-05	0.000187	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CD44—pancreatic cancer	1.28e-05	0.000186	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	1.28e-05	0.000185	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.26e-05	0.000183	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.26e-05	0.000182	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	1.25e-05	0.000181	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	1.25e-05	0.000181	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	1.24e-05	0.00018	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	1.23e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GCG—pancreatic cancer	1.23e-05	0.000178	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.21e-05	0.000176	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.2e-05	0.000174	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	1.2e-05	0.000174	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.2e-05	0.000174	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	1.19e-05	0.000173	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.19e-05	0.000172	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	1.16e-05	0.000168	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.16e-05	0.000168	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—STK11—pancreatic cancer	1.15e-05	0.000168	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	1.15e-05	0.000167	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SRC—pancreatic cancer	1.14e-05	0.000166	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.14e-05	0.000165	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOE—pancreatic cancer	1.14e-05	0.000165	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	1.12e-05	0.000162	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.11e-05	0.000161	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	1.11e-05	0.000161	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	1.1e-05	0.00016	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	1.1e-05	0.000159	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.09e-05	0.000158	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	1.09e-05	0.000158	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	1.09e-05	0.000158	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.08e-05	0.000157	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	1.08e-05	0.000157	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—pancreatic cancer	1.08e-05	0.000156	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.06e-05	0.000153	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	1.05e-05	0.000153	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	1.02e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—pancreatic cancer	1.02e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.02e-05	0.000148	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.01e-05	0.000147	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.01e-05	0.000146	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SRC—pancreatic cancer	1e-05	0.000145	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	1e-05	0.000145	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TYMS—pancreatic cancer	9.93e-06	0.000144	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—pancreatic cancer	9.89e-06	0.000144	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	9.8e-06	0.000142	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	9.75e-06	0.000142	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	9.71e-06	0.000141	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	9.66e-06	0.00014	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	9.63e-06	0.00014	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	9.46e-06	0.000137	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	9.46e-06	0.000137	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTEN—pancreatic cancer	9.39e-06	0.000136	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	9.36e-06	0.000136	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	9.18e-06	0.000133	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	9.13e-06	0.000132	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	9.01e-06	0.000131	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—pancreatic cancer	8.97e-06	0.00013	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	8.95e-06	0.00013	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	8.9e-06	0.000129	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	8.78e-06	0.000127	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	8.69e-06	0.000126	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SRC—pancreatic cancer	8.46e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—pancreatic cancer	8.4e-06	0.000122	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CD44—pancreatic cancer	8.37e-06	0.000121	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	8.29e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	8.24e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	8.16e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	8.14e-06	0.000118	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOE—pancreatic cancer	8.07e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	8.04e-06	0.000117	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCG—pancreatic cancer	8.03e-06	0.000116	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	7.85e-06	0.000114	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—pancreatic cancer	7.78e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	7.62e-06	0.000111	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—pancreatic cancer	7.58e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	7.57e-06	0.00011	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—STK11—pancreatic cancer	7.55e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	7.42e-06	0.000108	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—pancreatic cancer	7.37e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	7.29e-06	0.000106	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	7.1e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	7.05e-06	0.000102	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—pancreatic cancer	7.03e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	7.01e-06	0.000102	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTEN—pancreatic cancer	6.79e-06	9.85e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	6.62e-06	9.61e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.49e-06	9.42e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	6.44e-06	9.34e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	6.41e-06	9.3e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—pancreatic cancer	6.23e-06	9.04e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	6.22e-06	9.03e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	5.96e-06	8.64e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	5.58e-06	8.1e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	5.53e-06	8.03e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—pancreatic cancer	5.41e-06	7.85e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOE—pancreatic cancer	5.28e-06	7.66e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	5.26e-06	7.63e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.82e-06	7e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	4.79e-06	6.95e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.76e-06	6.91e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.6e-06	6.67e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.19e-06	6.08e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—pancreatic cancer	3.91e-06	5.68e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.65e-06	5.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.62e-06	5.25e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.4e-06	4.94e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.15e-06	4.58e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.78e-06	4.04e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.23e-06	3.23e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.82e-06	2.64e-05	CbGpPWpGaD
